CK Nutraceuticals partners with Kunpoong to distribute chitosan oligosaccharide

44d7d4b0-0873-4616-99a0-0f68e30897ffarticleimage.jpg

28 Sep 2017 --- South Korea’s Kunpoong Bio Co. Ltd., a global operator in the chitosan oligosaccharide market, has appointed Toronto-based CK Nutraceuticals (CK) as its exclusive North America sales, marketing and distribution partner for its Go2Ka1 ingredient (branded as KitoMax in North America).

CK focuses on supplying functional and nutritional ingredients for the functional food, beverage, dietary supplement and sports nutrition markets in North America. Kunpoong, based in Seoul, produces and supplies chitosan oligosaccharide for use in pharmaceutical, food and agricultural applications.

Under the terms of the multi-year agreement, CK is to promote advanced glucose management nutraceutical KitoMax to its extensive base of dietary supplement clients in both the US and Canada.

Solution backed by science
“We see increasing consumer and industry interest in the blood glucose management category, and we believe that KitoMax is a safe, effective and scientifically-proven solution in this important health category,” Michael Chernyak, President of CK Nutraceuticals, tells NutritionInsight.

KitoMax is a patent-pending chitosan-oligosaccharide produced using advanced enzymatic technology, the CK press release states. It has a well-defined mechanism of action, and is supported by three published clinical studies that demonstrate meaningful blood glucose control benefits.

CK adds that the applications of KitoMax include capsules, tablets, nutrition bars, stick packs, powdered drink mixes, gummies and more.

Several compelling structure/function claims have been defined for KitoMax in the US, and in Canada it has received a license from Health Canada with the approved claims “Helps to support healthy glucose metabolism,” “Helps to maintain healthy glucose metabolism,” “Helps maintain healthy blood sugar levels” and “Helps support healthy blood sugar levels.”

Chernyak also points to three published clinical trials that demonstrate: immediate effect on post-prandial blood glucose levels post-meal (sugar and bread/starch); and long-term administration effect, especially in reducing HbA1c and waist circumference.

“What is also important to note is that the long-term clinical trial was performed in a pre-diabetic population that was receiving no other medical intervention (to our knowledge, this is the only report of a natural product reducing HbA1c in pre-diabetic population),” Chernyak adds.

There is a team of scientists who collectively have more than 100 publications in the field of Type 2 diabetes prevention on board, Chernyak points out.

“We are thrilled to collaborate with Kunpoong Bio on this terrific ingredient, which we believe is very timely,” says Chernyak. “Our mission is to supply our North American clients with superior raw materials that are backed by scientific research of the very highest quality, and KitoMax certainly fits the bill.”

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

GOS holds dietary fiber potential: FrieslandCampina eyes new applications

13 Aug 2018 --- FrieslandCampina is targeting the dietary fiber opportunity for its Galacto-Oligosaccharides (GOS). The move comes in response to the recent FDA green light on specific dietary fibers which presents new market opportunities and application areas. “There is a lot of interest in clean, green and label-friendly ingredients and fiber is one that they are looking for, but in good tasting applications. This really means a lot more flexibility for formulators to offer something that has both prebiotic and fiber benefits,” Sarah Staley of FrieslandCampina tells NutritionInsight on the topic of GOS as a trending prebiotic fiber.

Health & Nutrition News

Australia’s Manildra Group launches low FODMAP flour

03 Aug 2018 --- Australian flour miller Manildra Group has launched a low FODMAP flour range, touted as being “the world’s first.” Tested by government-registered Australian certifier FODMAP Friendly with DTS laboratories, Lo-Fo Pantry Plain Flour has been approved for millions of Australians who suffer IBS-like abdominal symptoms but get no relief from a gluten-free diet. 

Health & Nutrition News

EFSA approves novel food status for AIDP's corncob XOS prebiotic

01 Aug 2018 --- Functional ingredients manufacturer AIDP has gained novel food status for its non-GMO, corncob XOS prebiotic, which is manufactured by LongLive, and sold in North America under the trademark PreticX, following approval from the European Food Safety Authority (EFSA). This new designation allows PreticX to be used in Europe and benefits AIDP’s customers who have international brands. PreticX had previously achieved FDA Generally Recognized as Safe status.

Health & Nutrition News

Infant nutrition collaboration: BASF and UC Davis to tap into gut-brain axis

26 Jul 2018 --- Further benefits of Human Milk Oligosaccharides (HMO) for infant formula hoped to be unlocked through a new BASF and the University of California Davis (UC Davis) collaboration. The long-term objective of the strategic partnership is to tap into the gut-brain axis by developing and validating second-generation HMO molecules as potent bioactive compounds. 

Health & Nutrition News

Infant nutrition advancements: BASF launches human milk oligosaccharide

17 Jul 2018 --- BASF is to launch 2’-fucosyllactose (2’-FL), a human milk oligosaccharide (HMO) for the infant nutrition market by early 2019 through its human nutrition brand, Newtrition. HMOs are a unique group of carbohydrates naturally found in human breast milk with 2’-FL being the most abundant. BASF reports it has successfully mastered the complete in-house development of 2’-FL from strain to downstream processing using a specifically stable HMO fermentation strain designed for large-scale production. 

More Articles
URL : http://www.nutritioninsight.com:80/news/ck-nutraceuticals-partners-with-kunpoong-to-distribute-chitosan-oligosaccharide.html